01 6Bristol-Myers Squibb Canada
02 2Gowling WLG (Canada) LLP
01 42250840
02 42317736
01 8Atazanavir Sulfate
01 8Capsule
01 42017-04-14
02 42018-12-22
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Brand Name : REYATAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Brand Name : REYATAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 100 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Brand Name : REYATAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Brand Name : REYATAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 150 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Brand Name : REYATAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Brand Name : REYATAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 200 mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Brand Name : REYATAZ
Patent Number : 2250840
Filing Date : 1997-04-14
Strength per Unit : 300mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2017-04-14
Date Granted : 2006-07-04
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
Brand Name : REYATAZ
Patent Number : 2317736
Filing Date : 1998-12-22
Strength per Unit : 300mg
Dosage Form : Capsule
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-22
Date Granted : 2004-11-02
